Delta variant facts from UT Health San Antonio experts
August 10, 2021
As children return to area schools this month, here are some points of interest about the delta COVID variant from experts at UT Health San Antonio.
Thinking impaired in COVID-19 survivors, study finds
August 2, 2021
In a sample of more than 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment.
Can a vitamin treat COVID-19-related acute kidney injury?
July 27, 2021
Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.
Message from the President: Announcement about delta variant and masks
July 20, 2021
We at UT Health San Antonio are closely monitoring the recent increase in community prevalence and transmission of the COVID-19 virus. At present, elsewhere and here in San Antonio, the latest surge is predominantly related to spread by the COVID delta variant. The delta variant is about four times more contagious than the original alpha variant and two times more lethal for unvaccinated people. Given the marked increase in community prevalence and spread, it is prudent that we increase our preventive protocols so that we can continue to keep on-campus transmission rates low.
UT Health San Antonio scientists continue relentless fight against COVID-19
June 28, 2021
Our biochemistry team learns more about how the coronavirus disguises itself in the body.
Traveling in a pandemic and the resumption of international business travel
June 23, 2021
By Chris Fuglestad, MFS, Office of International Services UT Health San Antonio international business will be considered again starting July 1. International business travel plays an integral role in the university’s mission to make lives better, and for many faculty members, the coronavirus pandemic brought international collaboration to an abrupt halt. But for Gabriel de Erausquin, MD, […]
